Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Mandarin Oriental Washington D.C.

Jan 25, 2016 8:30 AM - Jan 27, 2016 3:00 PM

1330 Maryland Avenue, SW, Washington, DC 20024

Pharmacovigilance and Risk Management Strategies 2016

Discuss opportunities, challenges, and practical aspects of managing risk in the context of benefits, for medical product safety and pharmacovigilance.

Luncheon in Exhibit Hall and Round Table Discussions

Session Chair(s)

Round Table  Discussions

Round Table Discussions

, United States

There will be a 30-minute session for a limited number of participants to join round table discussions during the lunch break. Key thought leaders will help facilitate the discussion.

Speaker(s)

Valerie E. Simmons, MD, FFPM

Valerie E. Simmons, MD, FFPM

Senior Medical Fellow, Global Patient Safety, Eli Lilly and Company Ltd, United Kingdom

Moderator: Topic #1 – Transition to the Evolving EU PVLegislation

Mick  Foy

Mick Foy

Director of Delivery, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Moderator: Topic #2 – Tell it to the Regulator: Share Your Challenges and Successes on Implementation of the EU PV Legislation

John A. Saunders

John A. Saunders

Sr. Business Systems Consultant, Abbvie, Inc., United States

Moderator: Topic #3 – FDA Project JumpStart

Roger A. Goetsch, PHARMD, RPH

Roger A. Goetsch, PHARMD, RPH

Pharmacist, Office of Surveillance & Epidemiology, CDER, FDA, United States

Co-moderator: Topic #4 – eReporting

Suranjan  De, MBA, MS

Suranjan De, MBA, MS

Deputy Director, Regulatory Science, OSE, CDER, FDA, United States

Co-moderator: Topic #4

Marie  Lindquist

Marie Lindquist

Director, Uppsala Monitoring Centre, Sweden

Moderator: Topic #5 – VigiAccess – The Public Access to the WHO ICSR Database

Jamie  Wilkins, PHARMD

Jamie Wilkins, PHARMD

Head, Risk Management Center of Excellence, Pfizer Inc, United States

Moderator: Topic #6 - Triggers for Modifying REMS

Sonja  Brajovic, MD

Sonja Brajovic, MD

Medical Officer, OSE, CDER , FDA, United States

Moderator: Topic #7 - MedRDA Coding and Suspect Product Reporting

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.